Physician profile
David Oni
NPI 1962176339
$3,078.28
in general payments reported to CMS, 2019-2025
13 companies · $2,165 in 2025
The $2,165 reported for 2025 was more than what 93% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $19.56 · 2024: $893 · 2025: $2,165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,589 · Travel and Lodging: $479 · Education: $10.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,588.85 |
| Travel and Lodging | $478.53 |
| Education | $10.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,053.53 | 2024-2025 | Spravato, Invega Sustenna, Invega Trinza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $419.68 | 2023-2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $357.16 | 2024-2025 | Uzedy, Austedo Xr, Austedo Xr |
| Alkermes, INC. | $278.17 | 2024-2025 | Lybalvi, Aristada |
| Neurocrine Biosciences, INC. | $218.24 | 2024-2025 | Ingrezza |
| Abbvie INC. | $146.05 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $132.95 | 2024-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Axsome Therapeutics, INC. | $119.07 | 2024-2025 | Auvelity |
| Neuronetics, INC. | $114.42 | 2025 | Neurostar Tms Therapy System |
| Takeda Pharmaceuticals U.S.A., INC. | $101.69 | 2024-2025 | Trintellix |
| Supernus Pharmaceuticals, INC. | $56.95 | 2025 | Qelbree |
| Lundbeck LLC | $40.89 | 2024 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $39.48 | 2025 | Cobenfy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Oni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.